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ABSTRACT: Small-angle neutron scattering (SANS) measurements were pursued to study
human vitronectin, a protein found in tissues and the circulation that regulates cell adhesion/
migration and proteolytic cascades that govern hemostasis and pericellular proteolysis. Many of
these functions occur via interactions with its binding partner, plasminogen activator inhibitor-1
(PAI-1), the chief inhibitor of proteases that lyse and activate plasminogen. We focused on a
region of vitronectin that remains uncharacterized from previous X-ray scattering, nuclear
magnetic resonance, and computational modeling approaches and which we propose is involved
in binding to PAI-1. This region, which bridges the N-terminal somatomedin B (SMB) domain
with a large central β-propeller domain of vitronectin, appears unstructured and has characteristics
of an intrinsically disordered domain (IDD). The eﬀect of osmolytes was evaluated using circular
dichroism and SANS to explore the potential of the IDD to undergo a disorder-to-order
transition. The results suggest that the IDD favors a more ordered structure under osmotic
pressure; SANS shows a smaller radius of gyration (Rg) and a more compact fold of the IDD upon addition of osmolytes. To
test whether PAI-1 binding is also coupled to folding within the IDD structure, a set of SANS experiments with contrast
variation were performed on the complex of PAI-1 with a vitronectin fragment corresponding to the N-terminal 130 amino
acids (denoted the SMB-IDD because it contains the SMB domain and IDD in linear sequence). Analysis of the SANS data
using the Ensemble Optimization Method conﬁrms that the SMB-IDD adopts a more compact conﬁguration when bound to
PAI-1. Calculated structures for the PAI-1:SMB-IDD complex suggest that the IDD provides an interaction surface outside of
the primary PAI-1-binding site located within the SMB domain; this binding is proposed to lead to the assembly of higher-order
structures of vitronectin and PAI-1 commonly found in tissues.

V

full-length structure has not been determined. During
biosynthesis, removal of a 19-residue signal peptide yields
the mature vitronectin chain of 459 amino acids (72 kDa);
further processing of mature vitronectin by proteolytic cleavage
at position 379 can produce a disulﬁde cross-linked form
comprising 62 and 10 kDa subunits. A genetic polymorphism
encoding Thr or Met as residue 381 controls the propensity of
vitronectin to be cleaved to the two-chain form;20 however, the
single- and two-chain variants appear to be functionally

itronectin (VN) was originally identiﬁed as a component
in serum that promoted adhesion of mammalian cells to
culture vessels.3,4 Antibody probes were used to show that VN
is also localized to cell surfaces and is abundant in the
extracellular matrix (ECM).5,6 VN has multiple binding
partners, including plasminogen,7 ﬁbrinogen,8 several integrins,9−11 urokinase plasminogen activator receptor,13 heparin,14 and plasminogen activator inhibitor-1 (PAI-1).15 These
partners aﬀect the structure and function of VN; in turn,
binding to VN can alter the structure, activity, and localization
of several of its binding partners.16−19
While there has been much interest in how vitronectin
function relates to the folding of this multidomain protein, the
© 2019 American Chemical Society
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Figure 1. Analysis of the intrinsic disorder predisposition of human vitronectin and the potential of the IDD to adopt structure. The domain
organization of vitronectin is shown in the linear structure between panels and a and b.1 The N-terminal somatomedin B domain is colored blue,
the central domain characterized by a β-propeller structure green, and the C-terminal domain corresponding to a half-propeller structure red. The
proposed IDD corresponding to the linker region (residues 48−130) is highlighted in amber. (a) Evaluating the intrinsic disorder propensity of
human VN (UniProt ID P04004). Disorder propensity was evaluated by PONDR VLXT (black curve), PONDR VL3 (red curve), PONDR VSL2
(green curve), PONDR FIT (pink curve), IUPred_short (yellow curve), and IUPred_long (blue curve). The DisProt database (http://original.
disprot.org/)2 was the source used to calculate the per-residue disorder predictors of the PONDR family. The results for the per-residue disorder
propensity calculated by these tools are given as real numbers between 1 (ideal prediction of disorder) and 0 (ideal prediction of order). A
threshold of ≥0.5 was used to identify disordered residues/regions in vitronectin, whereas those with disorder scores ranging from 0.2 to 0.5 are
classiﬁed as ﬂexible. Mean disorder predisposition was calculated by averaging all predictor-speciﬁc per-residue disorder proﬁles (bold, dashed, dark
cyan curve). The light blue shadow around the mean disorder curve shows the distribution of standard deviations. Shaded areas represent positions
of various VN domains. (b) Evaluation of the IDD sequence identiﬁed regions that may adopt helical structure. The amino acid sequence is shown
below the expanded IDD from the main schematic representation of the multidomain structure of VN. The two segments of the IDD identiﬁed by
the MoRF prediction software12 that may assume an α-helical structure upon binding are colored blue.

indistinguishable.21 X-ray scattering and computational predictions for the full-length protein, along with experimental
structures determined for the N-terminal somatomedin B
(SMB) domain, have led to a proposed domain organization
and three-dimensional models for vitronectin.1,22−26 This
domain structure is illustrated in Figure 1. The SMB domain
within vitronectin corresponds to its ﬁrst 44 amino acids, with
a partial 310-helix and a single turn α-helix as the only classical
secondary structural elements; the remainder consists of
unstructured sequences (loops and coils) connected by four
disulﬁde bonds. The third and fourth domains of VN, denoted
the central domain (amino acids 131−342) and the C-terminal
domain (amino acids 347−456), respectively, feature high βstructure content. Computational predictions indicate that the
central domain adopts a β-propeller structure and the Cterminal domain assumes a β-blade (half-propeller) fold.1,27
Between the ﬁrst and third domains lies a second region,
which is an ∼80-amino acid stretch that contains no predicted
secondary structure. This linker region is characterized by
features typically associated with an intrinsically disordered
domain.28,29 These characteristics generally include the
existence of low sequence complexity and bias in amino acid
content; in particular, these regions typically house a large
number of polar and charged amino acids (Gln, Glu, Lys, Pro,

and Ser) but have few bulky hydrophobic residues (Ile, Leu,
Met, Phe, Trp, Tyr, and Val).30,31 Investigations of intrinsically
disordered regions within proteins have revealed noteworthy
structure−function properties.32,33 Often, intrinsically disordered proteins or domains adopt secondary structures or threedimensional conformations that are induced upon binding to
partner proteins/ligands.34 Barring the adoption of speciﬁc
secondary structure, disordered regions can also interact with
binding partners via “disordered” loops. The versatility of these
disordered regions and their ability to adopt a variety of folds
when interacting with diﬀerent partners often lead to diversity
in binding targets.35,36 Evaluating features of the linker region
of VN as an intrinsically disordered region can provide new
insights into the role of this domain in physiological functions.
When VN interacts with PAI-1, an irreversible structural
change in VN occurs, leading to the accumulation of VN
oligomers.37 Work over many years has shown that PAI-1- and
VN-binding surfaces are extensive, and some have proposed
that two distinct binding sites exist for these proteins. The
primary binding sites on PAI-1 and VN are well-characterized.38,39 These involve interactions between the ﬂexible joint
region in PAI-1, containing helices D−F, and the SMB domain
of VN.38,40,41 Progress was made recently in our laboratory
using mutagenesis and monoclonal antibodies to identify a
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etry (MALDI-TOF-MS) were utilized to determine size,
identity, and purity during protein puriﬁcation.
Expression and Puriﬁcation of Deuterated PAI-1.
Deuterated PAI-1 was prepared using two diﬀerent approaches
in this study. Glycerol stocks of E. coli containing PAI-1 cDNA
in a pET-32b vector were ﬁrst grown overnight in 10−15 mL
of deuterated medium (TB with 50 μg/mL kanamycin and 34
μg/mL chloramphenicol) to generate starter cultures. The
following morning, these starter cultures provided the
inoculum for 4 L of deuterated medium. The large cultures
of deuterated protein were grown while being shaken at 220
rpm (1 rpm = 0.0167 Hz) at 37 °C until the OD600 reached ∼2
and then cooled to 15 °C prior to induction of protein
expression by addition of 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). Eighteen hours after induction, cultures
were harvested by centrifugation to isolate cell pellets, which
were frozen at −80 °C until protein puriﬁcation commenced.
Fermentation in minimal medium using the Biodeuteration
lab at Oak Ridge National Laboratory was also used to more
eﬃciently and cost eﬀectively deuterate PAI-1. Starter cultures
were grown, as described above, in a 70% deuterated minimal
medium. An inoculum from the starter cultures was added to a
1 L culture, and cells were grown to an OD600 of ∼35. The
culture was cooled to 15 °C, and IPTG was added to induce
protein expression with overnight incubation as described
above. On the basis of the starting level of D2O in the medium,
the ﬁnal level of deuteration of PAI-1 was expected to be 60−
65%.
For these experiments, a form of PAI-1 with tryptophan 175
replaced with phenylalanine (W175F) was utilized because of
its known slow rate of refolding from an active conformation to
the inactive, latent form.49 Deuterated W175F PAI-1 was
puriﬁed as previously described,48 using a three-step protocol
that includes cation exchange chromatography using SPSepharose, IMAC using a nickel-charged resin, and ﬁnally
size exclusion chromatography on a Sephacryl S-100 column.
All buﬀers were prepared in H2O, and the deuterated form of
PAI-1 isolated via the puriﬁcation protocol was immediately
dialyzed into PBS buﬀer [140 mM NaCl, 3 mM KCl, 10 mM
Na2HPO4, and 2 mM KH2PO4 (pH 7.4)] in D2O and then
frozen at −80 °C. Puriﬁcation was conﬁrmed by SDS−PAGE,
accompanied by Western blotting, and MALDI-TOF-MS.
Circular Dichroism (CD). Circular dichroism spectra were
measured at 20 °C on samples in PBS buﬀer using a model 202
Aviv circular dichroism spectrometer using 1 mm path-length
quartz cuvettes. The online tool Dichroweb was used to
analyze data to calculate secondary structure content.50,51
Buﬀer background scans included the same weight percent of
PEG-400 and EG and were subtracted from the corresponding
protein sample scans.
Small-Angle Neutron Scattering (SANS). SANS experiments were conducted at 20 °C on protein samples in PBS
buﬀer on the Bio-SANS (CG-3) beamline at the High Flux
Isotope Reactor (HFIR) and the EQ-SANS (BL-6) beamline
at the Spallation Neutron Source (SNS), both located at Oak
Ridge National Laboratory (ORNL). SANS studies using
osmolytes were conducted on Bio-SANS using neutrons at a
wavelength λ of 6.0 Å with a wavelength spread (Δλ/λ) of 0.14
and sample-to-detector distances of 1.2 and 6.9 m.52 SANS
contrast variation studies were conducted on EQ-SANS using
the 30 Hz mode and a 4 m sample-to-detector distance to
achieve 2.5−6.1 and 9.4−13.1 Å wavelength bands.53 The
wavevector transfer is q = 4π sin(θ)/λ, where 2θ is the

more expansive binding interface that houses a separate
binding site for VN on PAI-1.41 This site contains several basic
residues and overlaps in part with the locus for the binding of
heparin to PAI-1.41 However, the location of a corresponding
second binding site for PAI-1 on VN has not been resolved.42
In early studies, two diﬀerent regions were suggested to house
such a second PAI-1-binding site, but neither has been
substantiated in further work. One notion was that the site is
located within the heparin-binding domain, which includes
residues 348−370 within the C-terminal domain of VN,43,44
whereas a diﬀerent binding site was proposed in the vicinity of
amino acids 115−121.45
In this study, our goal was to characterize the secondary
binding site within vitronectin. We hypothesize that the linker
region of vitronectin is an intrinsically disordered domain
(IDD) that houses the additional binding site for PAI-1 on
VN. We also hypothesize that this IDD region undergoes a
transition from a disordered to a more ordered structure when
PAI-1 binds to VN. We note the number of negatively charged
residues within the IDD (sequence given in Figure 1b) that
could form ionic bonds with basic residues in the extensive
binding site recently characterized in PAI-1.41 Furthermore,
the ﬂexibility of the IDD is compatible with the hypothesis that
the primary and secondary binding sites of VN are proximal to
one another. This study employs sophisticated structural
methods to determine the eﬀect of PAI-1 binding on the
structure of this linker region within VN. In a recent
complementary investigation, we used truncated forms of
vitronectin (SMB-IDD fragments) to pursue kinetic analyses
that support this assignment for the secondary binding site.46
Our discoveries advance the ﬁeld by providing structural
information about an understudied domain of VN and
generating models to understand how PAI-1 interactions in
this region are key within the multistep pathway of assembly of
PAI-1:vitronectin complexes that associate into higher-order
forms and display altered cell binding and adhesion.

■

MATERIALS AND METHODSA
Bacterial Expression and Puriﬁcation of the SMB-IDD
Fragment. Amino acids 1−130 of VN (the SMB-IDD
fragment) were engineered into the pET-32b plasmid,
containing thioredoxin and six-histidine tags. The polyhistidine
tag was included to aid in puriﬁcation by immobilized metal
aﬃnity chromatography (IMAC). The thioredoxin tag was
included to prevent accumulation of recombinant protein
fragments in inclusion bodies and thus improve solubility.47
The pET-32b-SMB-IDD plasmid was transformed into Rosetta
gami2(DE3) pLysS Escherichia coli cells, and SMB-IDD was
expressed and puriﬁed using previously published procedures.48 After the cell pellet had been collected and lysed,
the soluble cell lysate was chromatographed on an IMAC
column charged with nickel, using a linear gradient from 20 to
1000 mM imidazole for elution. Fractions that contained the
vitronectin fragment fused with thioredoxin were collected and
enzymatically digested with thrombin. After protease treatment, the protein digest was subjected to a second separation
on the nickel-charged IMAC column, to which the fusion tags
remained bound. The fractions that did not bind to the IMAC
column were then loaded on an aﬃnity column prepared with
bound W175F PAI-1 to select the properly folded vitronectin
fragment, which bound to the column, as described elsewhere.48 Sodium dodecyl sulfate−polyacrylamide gel electrophoresis (SDS−PAGE), Western blotting, and mass spectrom5119
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I(0) can be expressed as a function of the contrast Δρ as

scattering angle. Circular quartz cuvettes (Hellma USA,
Plainville, NY) with a 1 mm path length were used for
SANS measurements on protein samples. Standard procedures
for data analysis employed MantidPlot.54 The observed
scattering intensity was mathematically corrected for detector
sensitivity and the measured scattering contribution from the
solvent and empty cells. The corrected scattering intensity was
then adjusted to an absolute scale using a calibrated standard.55
SANS Contrast Variation Measurements. SANS contrast variation was performed on the PAI-1:SMB-IDD complex
using 60% deuterated W175F PAI-1 and protiated SMB-IDD
at various D2O buﬀer percentages (0%, 20%, 85%, and 100%
D2O). The sample concentration was 7.7 mg/mL in all cases.
Figure S4 shows a plot of the neutron scattering-length density
(SLD, often written as ρ) versus the percent of D2O in the
solvent for water (black line), a protiated protein such as SMBIDD (blue line) and a 60% deuterated protein (red line) such
as PAI-1. The plot shows that the SLD of water varies from
−0.56 × 1010 cm−2 for 0% D2O, i.e., H2O, to 6.4 × 1010 cm−2
for 100% D2O. The slopes of the lines for the proteins are not
as steep as that for water, so the protein and water lines cross
each other. Those points are called match points, because the
SLDs of protein and water are the same. Thus, the contrast
between protein and water (two-sided black arrow shown at
20% D2O in the ﬁgure), often written as Δρ, is zero at these
match points, meaning that the scattering intensity of protein is
zero under these conditions. The match point between 60%
deuterated protein and water occurs at 85% D2O, as illustrated
by the green circle in the ﬁgure. This means that, for a complex
consisting of protiated protein and 60% deuterated protein, the
scattering from the latter is matched out in 85% D2O buﬀer,
and the only component scattering is the protiated protein,
which in this case is the SMB-IDD. In 20% D2O buﬀer, neither
component is matched out. However, the contrast between
60% deuterated protein and water is larger than that between
protiated protein and water. This is true to an even greater
extent in 0% D2O buﬀer. Thus, the scattering from 60%
deuterated PAI-1 dominates the total scattering from the
complex in 0% and 20% D2O buﬀers but is completely absent
in 85% D2O buﬀer and contributes weakly in 100% D2O
buﬀer.
SANS measurements with osmolytes used protiated SMBIDD in the presence of varying concentrations of deuterated
ethylene glycol (EG) (Cambridge Isotope Laboratories,
C2D6O2). Deuterated EG has a match point at 100% D2O.
Thus, the measurements were performed in 100% D2O buﬀer
to match out deuterated EG so that only the contribution from
SMB-IDD is being measured.
The Guinier approximation56
ij
R 2 yz
j
2 g z
j
zz
I(q) = I(0) expjj−q
j
3 zz
k
{

I(0) = n(Δρ)2 V 2

where n is the number density of molecules in solution, which
is proportional to the sample concentration, and V is the
molecular volume. Because I(0) is proportional to c and Δρ2,
and Δρ2 is dependent on the percent of D2O in the solvent,
the x-intercept of a linear ﬁt to I(0)/c versus percent D2O in
the solvent is at the contrast match point of the complex. If the
sample concentrations are the same at all contrasts measured,
then I(0) versus percent D2O can be used instead. The
quality of the data can be tested by also calculating the match
point of the complex from the amino acid sequences of the
components.57,58 If the complex was formed as expected, the
calculated and experimentally determined match points should
agree with each other.
Analysis of SANS Data using Stuhrmann Analysis and
the Parallel Axis Theorem. The Rg values obtained from the
data at each contrast can be described by the equation59
R g 2 = R m2 +

ln[I(q)] = ln[I(0)] − q

R g 2 = f1 R12 + f2 R 2 2 + f1 f2 DCM 2

(4)

(5)

where R1 and R2 are the radii of gyration of the components
and DCM is the CM distance between the two components.61
Here

fi =

Δρi Vi
ΔρV

(6)

where Δρi and Vi refer to components 1 and 2 and Δρ and V
refer to the entire complex. The radii of gyration of the
components and the CM distance between them are obtained
from the parallel axis theorem directly, whereas these
parameters are calculated from the deﬁnitions of α and β
when using the Stuhrmann analysis.57 Both analyses were
performed on the PAI-1:SMB-IDD contrast variation data
using the MULCh software.57 The 0%, 20%, and 85% D2O
conditions were used in the analyses.
Analysis of SANS Data using EOM. The SMB-IDD
structure, with and without added osmolytes, was assessed
using the EOM program within the ATSAS program suite.62
The same software was used to determine the ﬂexibility of the
unbound and PAI-1-bound forms of SMB-IDD. Known
sequence and structural information for the SMB-IDD served
as a basis to generate 10000 independent structures using

(1)

Rg2
3

β
α
−
Δρ
Δρ2

where Rm is the Rg value of the equivalent complex with a
homogeneous scattering-length density, α is the second
moment of the SLD ﬂuctuations, and β is the square of the
ﬁrst moment of the SLD ﬂuctuations. For two-component
systems with diﬀerent SLDs such as protiated SMB-IDD and
60% deuterated PAI-1, α describes the distribution of SLDs
relative to the center of mass (CM) of the complex, and β is
related to the separation distance between the scattering CM
of the two components (CM distance).60 A Stuhrmann plot59
of Rg2 versus Δρ−1 (from eq 4) is used to determine Rm, α, and
β. If the plot is linear (β = 0), the CMs of the two components
are concentric and the sign of the slope, α, indicates whether
the component with the higher SLD is on the interior or
exterior of the complex.
A related equation is the parallel axis theorem

was applied to the low-q region of the data to yield values for
Rg and I(0). This approach is valid only for the data region
where QRg ≲ 1.3Rg. Taking the natural log of the Guinier
approximation (eq 1) results in
2

(3)

(2)

Rg is obtained from the slope of a linear ﬁt to ln[I(q)] versus q2
(eq 2), and I(0) is obtained from the intercept.
5120
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Starting Structure 3. Starting structure 3 incorporated
additional constraints to produce a starting structure that had a
CM distance between the two components (20.8 Å) that was
more comparable to that calculated from the experimental data
[18 ± 1 Å (see Table S2)]. Force was applied to the IDD from
starting structure 2 via the interactive molecular dynamics
(MD) option within Visual Molecular Dynamics78 to orient
the IDD on the opposite side of PAI-1, lying across the central
β-sheet. Energy minimization of this model for 5000 steps
yielded starting structure 3.
From each of these starting structures, 50000 additional
structures were generated. The Complex Monte Carlo module
in SASSIE was used to vary the disordered portion of the VN
component, generating ensembles of structures from the three
starting PAI-1:SMB-IDD structures for comparison to SANS
data. Conﬁgurations were generated by sampling backbone
dihedral angles using CHARMM-27 all-atom protein force
ﬁeld parameters.79 Each new conﬁguration was checked for
overlap of α-carbon atoms. If the overlap distance between
these atoms was ≥3 Å, the new structure was accepted. To
eliminate structures with correlated dihedral angle moves, only
every 10th accepted structure was selected for further analysis.
The ﬁnal ensembles consisted of 3000−5000 accepted
structures. A second Complex Monte Carlo run was performed
from starting structures 1 and 3 in which Rg was constrained to
values of <35 Å to obtain more structures with Rg values close
to that obtained from the data. These ﬁnal ensembles
contained approximately 2000 structures.
The 0%, 20%, and 85% D2O samples were used in the
structure modeling analysis of the PAI-1:SMB-IDD complex.
SANS curves were calculated for the ensembles of PAI-1:SMBIDD model structures with the SasCalc80 module in SASSIE,
using the converged number of golden vectors option and a
tolerance of 0.001. A H−D exchange fraction of 0.95 was used
for the PAI-1 and VN components, and the PAI-1 component
was assumed to be 60% deuterated. For SMB-IDD alone in
solution, a H−D exchange fraction of 0.95 was used.
The calculated SANS curves were compared to data using
the χ2 ﬁlter module in SASSIE. The χ2 equation was used to
assess the goodness of ﬁt to the data.

default EOM settings.63−66 EOM-calculated scattering curves
of these structures were judged in comparison to the
experimental SANS data using a genetic algorithm to select
1000 structures that average to best ﬁt the SANS measurements. The results are represented as a distribution in Rg. For
the complex, the SANS data collected on the deuterated PAI1:SMB-IDD complex in 100% D2O were used, where the
SMB-IDD signal is dominant. The Protein Data Bank (PDB)
coordinates for SMB-IDD were extracted from the selected
EOM structures, and the Rg of the ensemble (SMB-IDD only)
was calculated using CRYSOL67 to directly compare with the
Rg distribution from unbound SMB-IDD.
Analysis of SANS Data using SASSIE. SASSIE68 was
developed at the National Institute of Standards and
Technology (NIST) as a suite of software tools for rendering
high-resolution representations of protein structures and/or
complexes that ﬁt to the corresponding SANS data. The
beginning point in generating these models was energy
minimization to produce “starting structures” with all-atom
atomic coordinates using the co-crystal structure for the PAI1:SMB complex (PDB entry 1OC0)49 as the basis data set.
Several amino acid replacements were modeled into this
structure, including the W175F point mutation, the ﬁve
residues missing from the N-terminus, and the short segment
of the reactive center loop (RCL) that is not resolved in the
crystal structure. NAMD was used for energy minimization of
the RCL for 1000 steps.69 Subsequently, energy minimization
of the rebuilt PAI-1 structure was implemented for an
additional 1000 steps. Torsion-angle molecular dynamics70
(10 ps) were applied to the RCL portion of the resulting
minimized PAI-1 structure; the ﬁnal frame was adopted as the
PAI-1 component within each of the calculated starting
structures.
Starting Structure 1. For all three starting structures, the
SMB domain within the SMB-IDD was generated from the
three-dimensional coordinates for the SMB structure in the cocrystal (PDB entry 1OC0), which deﬁned the PAI-1:VN
interface. A segment of 10 disordered residues was added to
the known SMB structure, based on data from the published
nuclear magnetic resonance (NMR) structure.71 For starting
structure 1, the additional residues up to the end of the IDD
sequence were added and allowed to be ﬂexible, absent any
constraints in the energy minimization. NAMD was used to
minimize the SMB-IDD structure for 1000 steps. Finally, the
separately minimized PAI-1 and VN structures were built back
into a single model for an additional 1000 steps of energy
minimization to produce starting structure 1.
Starting Structure 2. For the second structure, a similar
approach was taken as with construction of starting structure 1,
but structural constraints were imposed on the IDD segment.
Speciﬁcally, a compact structure for the IDD portion of
starting structure 2 was desired, for better agreement with the
experimentally determined Rg. PSIPRED, PHYRE2, ChouFasman, GOR, and neural network were used72−77 to predict
helical regions and seek agreement from more than one
method. Even though some algorithms predicted short helical
regions, no segment of the IDD was consistently predicted as
helical comparing these methods, so none was introduced.
Nonetheless, PSIPRED yielded a more compact structure for
the IDD, which was incorporated into the model rather than
the extended IDD without constraints in starting structure 1.
Energy minimization of this model for 5000 steps yielded
starting structure 2.

χ2 =

1
N−1

∑
q

[Iexp(q) − Icalc(q)]2
σexp(q)2

(7)

where Iexp(q) is the experimental SANS intensity curve, Icalc(q)
is the calculated SANS intensity curve from the model
structure, and σexp(q) is the q-dependent error of the Iexp(q)
values. The sum was taken over 51 data points (N) in this case.
A χ2 versus Rg analysis provided a measure of how well the
individual structures generated from each starting structure ﬁt
the data and which starting structure resulted in the best ﬁts to
the data. Structure ensembles were further evaluated on the
basis of the shapes of the χ2 versus Rg plots to ﬁnd the best ﬁt
ensemble of structures. Surface density plots showing the range
of conformational space covered by the IDD region were made
using the Density Plot module of SASSIE. This provided a
visual comparison of the conformational space spanned by
SMB-IDD when bound to PAI-1 and when free in solution.

■

RESULTS
Computational Predictions of the Intrinsically Disordered Nature and Potential of the IDD To Adopt
Structure. In line with the considerations discussed in the
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Figure 2. Eﬀects of osmotic pressure on the secondary structure of the SMB-IDD fragment of VN. (a) CD spectra collected at various
concentrations of osmolytes: black line, isolated SMB-IDD; pink line, SMB-IDD with 57% EG added; blue line, SMB-IDD with 57% PEG-400
added. (b) Secondary structure components calculated from the CD data, signifying a decrease in the level of disorder and an increase in the level
of structure with the IDD of VN under osmotic pressure: black, isolated SMB-IDD; pink, SMB-IDD with 57% EG added; blue, SMB-IDD with
57% PEG-400 added.

ligand. These predictions bolster the hypothesis that binding to
PAI-1 leads to a change in the conformation of the IDD of VN.
Using Circular Dichroism To Study the Eﬀect of
Osmolytes on the Vitronectin IDD Structure. In the
pursuit to determine whether this interdomain sequence
(amino acids 48−130) from VN exhibited properties expected
for an IDD region, we evaluated the ways in which osmolytes
aﬀect the structure of the IDD. Osmotic pressure, which
perturbs the solvation of a protein, is frequently used to
interrogate folding propensity and reveal structural changes
that could be obscured in the presence of binding
partners.93−95 In particular, osmolytes have been especially
useful in studies to demonstrate folding in intrinsically
disordered proteins, due to the crowding eﬀect that emulates
cellular conditions and confers compaction and adoption of
structure in predisposed regions.96−99
We utilized far-ultraviolet (far-UV) CD to study the eﬀect of
osmotic pressure on secondary structure within the IDD.
Ethylene glycol (EG) and polyethylene glycol (PEG) 400 were
employed to test for structural changes within the IDD that
may be induced by changes in osmotic pressure. The results
indicated that the SMB-IDD fragment alone exhibited
ellipticity characteristic of a protein fold devoid of classical
secondary structure elements (Figure 2a). However, upon
addition of either osmolyte, we observed the ellipticity
measured for SMB-IDD shifted toward 220 nm, indicating a
reduction in the level of disorder and a gain of some ordered
secondary structure (Figure 2a). The two diﬀerent osmolytes,
EG and PEG-400, were used to assess any osmolyte size
eﬀects. For the same weight percent, PEG-400 has an osmotic
pressure that is lower than that of EG. However, PEG-400
induced more secondary structure in SMB-IDD compared to

introductory section, Figure 1a shows the results of the
multiparametric evaluation of the predisposition for intrinsic
disorder across the entire sequence of human vitronectin
(UniProt ID P04004) employing several frequently used
disorder predictors, including PONDRVLXT,81 PONDR
VSL2,82 PONDR VL3,82,83 PONDR FIT,84 IUPred_short,
and IUPred_long.85,86 The rationale for the selection of these
tools is provided in previous publications.87,88 Also, the average
of the outputs of these six per-residue disorder predictors was
used to calculate a mean per-residue intrinsic disorder proﬁle
for vitronectin. The use of consensus or mean disorder
propensity is consistent with empirical observations, indicating
that this strategy typically increases the predictive performance
compared to the use of a single predictor.89−91 The individual
computational tools and consensus disorder propensity in
Figure 1a uniformly indicate that the IDD from vitronectin is
predicted to be highly disordered.
A hallmark feature of many intrinsically disordered domains
is their ability to adopt structure upon interaction with a
binding partner. To test the potential of the IDD of VN to
behave similarly, we analyzed the IDD sequence using the
Molecular Recognition Feature (MoRF) algorithm.12 Within
intrinsically disordered proteins, MoRFs are segments that are
predicted to undergo a change from disorder to order when
bound to a ligand. The ordered conformation acquired by the
protein varies and could include adoption of secondary
structure or folding to an ordered loop structure.92 The results
of the MoRF prediction for the vitronectin IDD are shown in
Figure 1b, identifying two segments within the IDD (VN
residues 52−72 and 84−95) that may adopt α-helical structure
in a coupled folding−binding event upon interaction with a
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Figure 3. (a) Eﬀect of osmotic pressure on the structure of the SMB-IDD measured by SANS. Rg values from SANS measurements on SMB-IDD
in 100% D2O with addition of deuterated EG are plotted vs osmolyte concentration. Error bars represent the standard deviation. (b) Heat map
from EOM analysis to illustrate eﬀects of osmotic pressure on the size of the SMB-IDD. The SMB-IDD Rg distribution (x-axis, where the color bar
legend represents the relative frequency) is observed to shift to a lower range and narrow as osmotic stress is applied with deuterated EG (plotted
along the y-axis). Notably, the most prevalent Rg (dark blue) in the absence of osmolyte, which is ∼39 Å, decreases by ∼10 Å over the course of EG
addition, conﬁrming that osmolytes perturb the structure of the IDD.

Evaluating Changes in the IDD Structure That Occur
upon PAI-1 Binding Using Contrast Variation Measurements with SANS. Taken together, the results of assays with
osmolytes suggest that the IDD within vitronectin acquires
secondary structure as observed for many intrinsically
disordered proteins.93−99 These ﬁndings provide a rationale
for evaluating the association of PAI-1 with the vitronectin
fragment (SMB-IDD) to determine whether binding of a
cognate ligand also perturbs the folding of the IDD. For these
experiments, W175F PAI-1, deuterated to a ﬁnal level of 60%,
was produced to be used in combination with protiated SMBIDD in the measurements of the PAI-1:SMB-IDD complex to
diﬀerentiate scattering data between the two complex
components via contrast variation experiments. For the
contrast variation experimental design, the level of D2O in
the solution was varied so that the scattering signal from one of
the two proteins predominated under the varied solvent
compositions, thus exploiting the change in scattering that
occurs when deuterium is present. Collection of data at
multiple buﬀer D2O percentages allows for isolation and/or
suppression of components within the complex from the
scattering data as explained in Materials and Methods, so that a
model depicting the arrangement of the proteins within the
complex can be assembled. SANS data at four diﬀerent levels
of deuterated solvent are shown in Figure S2. Corresponding
Guinier plots (eqs 1 and 2) are shown in Figure S3, and Rg and
I(0) values for the data sets are listed in Table S1. Brieﬂy, the
Rg values obtained for the data in 0% and 20% D2O were
similar (25.45 ± 0.07 and 24.95 ± 0.09 Å, respectively),
whereas the value for 85% D2O is higher, at 28 ± 3 Å. Finally,
Rg in 100% D2O was found to be 31.3 ± 0.4 Å. Note that the
errors on the 0% and 20% D2O values are the standard errors
from the linear ﬁt to the Guinier equation. They are
approximately an order of magnitude smaller than the
sensitivity of the SANS technique under the best signal-tonoise conditions. On the other hand, the error on the 85%
D2O value was taken from an average value obtained from two

EG due to a larger excluded volume. A comparison of these
results shows that more than one osmolyte induces eﬀects on
SMB-IDD structure, pointing toward general action rather
than osmolyte-speciﬁc eﬀects. The far-UV CD results were
analyzed to identify changes in secondary structure with the
web-based tool, Dichroweb, which quantiﬁes α- and βstructures and loops. The CD experiments corroborated our
hypothesis that osmolytes can induce a disorder-to-order
transition in the IDD (Figure 2b).
Determining the Eﬀect of Osmolytes on the IDD
Structure Using Small-Angle Neutron Scattering
(SANS). The manner in which osmolytes perturb the structure
of the SMB-IDD was also investigated by SANS. Using
deuterated EG in a 100% D2O buﬀer to observe only protein
signal, SANS showed that addition of EG led to a smaller Rg
for SMB-IDD (Figure S1 and Figure 3a). This decrease in Rg
indicated that the solution structure for the IDD became more
compact with an increase in osmotic stress. EOM was
employed to provide additional in-depth analysis of the
SANS data. As described in Materials and Methods for this
approach, 10000 possible structures for the SMB-IDD were
generated, along with their corresponding scattering curves to
be compared with the measured SANS data. From the 10000
structures, the best ﬁtting 1000 were identiﬁed for each of the
osmolyte conditions in Figure 3a. Using the selected structures,
a heat map was generated comparing the Rg distribution as a
function of ethylene glycol concentration (Figure 3b). This
analysis indicates that the isolated SMB-IDD is a signiﬁcantly
ﬂexible structure, existing over a relatively broad Rg range of
∼20−55 Å, but sampling a signiﬁcantly smaller range when
under osmotic stress (Figure S1 and Figure 3b). This structural
transition, revealed by a smaller Rg range, could correspond to
an increase in the level of secondary structure and/or an
overall compaction of the IDD. While the limited resolution of
small-angle scattering approaches is insuﬃcient to distinguish
these two possibilities, the corresponding results from CD
indicated that some gain in secondary structure occurred.
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Guinier ﬁts in slightly diﬀerent q ranges, as the data were noisy
because only the VN component is scattering under these
conditions. Thus, the error is more in line with the sensitivity
of the SANS technique for measurements made under poor
signal-to-noise conditions. Finally, the error on the 100% D2O
value is in line with the sensitivity of the SANS technique
under the best signal-to-noise conditions.
A plot of I(0) versus percent D2O in the solvent (eq 3) is
shown in Figure S5. The x-intercept from a weighted linear ﬁt
(solid line) to the data yielded a match point of 76.29 ± 0.03%
D2O. Because all samples were at the same concentration (7.7
mg/mL), it was not necessary to divide I(0) by the
concentration to determine the match point. The match
point for the PAI-1:SMB-IDD complex obtained from the
amino acid sequences of the components was determined to be
77% D2O using both MulCh57 and the Contrast Calculator
module in SASSIE,68 assuming a 1:1 PAI-1:SMB-IDD complex
with PAI-1 60% deuterated. The agreement of the
experimental and calculated match point veriﬁes that PAI-1
is 60% deuterated as expected. Thus, PAI-1 was assumed to be
60% deuterated in a 1:1 PAI-1:VN complex for the Stuhrmann
and parallel axis theorem analyses as well as for calculation of
model SANS curves.
The results from the Stuhrmann and parallel axis theorem
analyses (eqs 4−6) of the 0%, 20%, and 85% D2O data are
shown in Table S2. Rg = 23.6 ± 0.1 Å for PAI-1, and Rg = 30.3
± 0.3 Å for SMB-IDD in the complex. The CM distance
between the two components is 18 ± 1 Å. In addition, the α
parameter from the Stuhrmann analysis was negative,
indicating that the component with the lower scattering-length
density (protiated SMB-IDD) lies toward the periphery of the
complex. Taken together, these results suggest that the IDD is
compact and located close to the PAI-1 component.
The 100% D2O data were not used in the ﬁnal Stuhrmann
and parallel axis theorem analyses or the structure modeling
because a valid result with positive Rg2 values in eqs 4 and 5
could not be obtained when these data were included. It is very
possible that there may be a small amount of D2O-induced
aggregation under these solvent conditions. The experimental
value for PAI-1 in the complex is somewhat larger than the Rg
value for PAI-1 of 21.2 Å calculated from the crystal structure
of isolated PAI-149 or 21.86 Å calculated for the PAI-1
component in our PAI-1:SMB-IDD starting structures. While
MD simulations could be performed on the PAI-1 component
in the complex to obtain a potential Rg value that is closer to
the experimental value, it was not found to be necessary to
obtain good ﬁts to the 0% and 20% D2O data.
For data analysis, we once again used EOM to provide
insight into whether the SMB-IDD adopted a more compact
structure in the presence of the PAI-1 ligand. As described in
Materials and Methods, we were able to determine the
individual contribution from the SMB-IDD in the PAI-1bound state. We compared the Rg values for free versus bound
SMB-IDD and observed that PAI-1 binding yields a shift in the
Rg range for the SMB-IDD to predominantly lower values,
consistent with a solution structure for the IDD that is
restricted in conformation upon binding (Figure 4). An
important question is the stoichiometry of the complexes
measured in this study, which cannot be assumed and must be
measured in the SANS work. Our prior work using
hydrodynamic methods with PAI-1 and full-length vitronectin
demonstrated that there is a 2:1 (PAI-1:vitronectin)

Figure 4. Comparison of Rg values from analysis by EOM for SANS
data on the PAI-1:SMB-IDD complex vs unbound SMB-IDD.
Evaluation of scattering curves by EOM for unbound SMB-IDD
indicates that the IDD samples a broad range of conformational space.
A comparison of the SANS data for unbound (black) vs bound (blue)
illustrates the shift in the Rg across the range upon PAI-1 binding,
corresponding to a predominance of conformations with a decreased
Rg when the ligand is bound.

stoichiometry of interaction that leads to assembly of higherorder oligomeric complexes via a prominent intermediate
containing four PAI-1 and two vitronectin molecules.100 Thus,
it was not clear whether we would observe a 2:1 or 1:1
interaction for PAI-1 with the truncated form of vitronectin
(SMB-IDD). The I(0) values calculated from the amino acid
sequences of the 60% deuterated PAI-1 and VN in 0%, 20%,
and 85% D2O, assuming a 1:1 complex at a concentration of
7.7 mg/mL, agreed with those obtained from the measured
SANS data (Figure S2 and Table S1), indicating that the
complex is 1:1 at these contrasts. This is supported by our
recent study using stopped-ﬂow kinetics to characterize
biphasic binding of PAI-1 with SMB-IDD versus monophasic
binding with SMB. 46 The biphasic binding observed
corroborates the binding of the IDD to PAI-1, with separate
binding rates for the SMB and IDD regions; this prior work
also demonstrated a 1:1 binding between these proteins.46
Structural Modeling of the SMB-IDD from SANS
Analysis. To generate reasonable models for the SMB-IDD,
free and bound to the PAI-1 ligand, we generated a large set of
possible structures and their corresponding scattering patterns
to compare with the measured SANS data. These calculations
utilized the SASSIE software suite, as described in Materials
and Methods. The analysis begins by generating starting
structures and using Monte Carlo and MD approaches to
explore protein conformations that are consistent with the
measured SANS data. The starting structures are shown in
Figure 5. Brieﬂy, starting structure 1 was created without
constraints on the IDD; starting structure 2 was produced with
Rg constraints on the IDD that yield a more compact structure
that better matched the experimental data, and starting
structure 3 was generated by constraining Rg and forcing a
closer approximation of the IDD and PAI-1 (i.e., the IDD
“wrapped around” PAI-1) to better align with the CM distance
calculated from the SANS data. Also, a starting structure for
the unbound SMB-IDD was calculated without constraints on
the IDD (Figure 5). More details regarding the generation of
the starting structures are provided in Materials and Methods.
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Figure 5. Starting structures for evaluating SANS data on the PAI-1:SMB-IDD complex or unbound SMB-IDD. Starting structures representing
unbound SMB-IDD or the PAI-1:SMB-IDD complex were generated as basis data sets for employing Monte Carlo and molecular dynamics
methods to calculate sizable, conformationally diverse pools of structures for data analysis. The three starting structures for SMB-IDD bound to
PAI-1 were produced with the all-atom calculator within the SASSIE tool suite. Structure 1 lacked constraints on the IDD. Structure 2 was
calculated with the IDD in a more compact conformation. Structure 3 was generated with the compact IDD conformation in close proximity to
PAI-1. A single starting structure for the free SMB-IDD was used for analysis of the corresponding SANS data. PAI-1 is colored green, the SMB
domain cyan, and the IDD amber.

ﬁts to the experimental data, although a signiﬁcant number of
structures exhibit reasonable χ2 values.
Density plots were generated to aid in the visualization and
comparison of the three-dimensional space accessed by the
ﬂexible IDD under both conditions. Figure 8a presents a
density plot representing all structures that ﬁt to the data with
a χ2 of <1.5 for the free SMB-IDD. The cyan shape in the
center of the diagram corresponds to the SMB, and the gray
cloud represents the conformational space occupied by the
ensemble of calculated structures for the IDD. For comparison,
Figure 8b provides an overlay of the density plot of the data
from SMB-IDD bound to PAI-1 (using starting structure 1)
and the density plot for the unbound SMB-IDD. As with panel
a, the cyan structure represents the SMB domain, and the
green structure in the center represents PAI-1. The amber
coloring is a representation of the area of χ2 < 4 conformational space sampled by the IDD when PAI-1 is bound to the
SMB-IDD, to be compared with the cloud of χ2 < 1.5
conformational space for the unbound IDD shown in the
lighter gray representation. As observed in the overlay in
Figure 8b, the IDD conformations for SMB-IDD bound to
PAI-1 inhabit the region surrounding PAI-1 and represent a
smaller region of conformational space compared to the
unbound SMB-IDD alone. This three-dimensional representation of the free and bound forms of SMB-IDD supports the
EOM analysis and expands upon it with a visualization of the

From each of the three starting structures for the SMB-IDD
complex (Figure 5), pools of 3000−5000 accepted (nonoverlapping) conformations were generated as described in
Materials and Methods. Calculated scattering data for these
pools of structures were compared to the experimental SANS
data, and χ2 values (eq 7) were assessed as a measure of the
goodness of ﬁt. The χ2 versus Rg values for the three individual
structures are compared for the 85% D2O contrast solution in
Figure 6a. The 85% D2O contrast was selected because PAI-1
with 60% deuteration is matched out under these conditions
(match point of 85% D2O as shown in Figure S4), so that
SMB-IDD dominates the measurement in this case. The best
ﬁt to the measurements in 85% D2O is observed with the two
pools arising from starting structure 1 (colored red and black).
The ensemble colored red, in which Rg was constrained to <35
Å, was further analyzed by calculating χ2 versus Rg at the other
two measured contrasts, 0% and 20% D2O. The results are
shown in Figure 6b, where the red points for the 85% D2O
data are the same as the red points in Figure 6a, the gray points
are for the 20% D2O data, and the purple points are for the 0%
D2O data.
Additionally, the χ2 versus Rg correlation for the SANS
measurements on the isolated SMB-IDD is plotted in Figure 7.
As observed for the PAI-1:SMB-IDD complex, a subset of
structures for the unbound SMB-IDD does not provide good
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Figure 6. (a) χ2 vs Rg correlation for SANS on PAI-1:SMB-IDD in the 85% D2O contrast solution. The starting structures for the complex, shown
in Figure 5, were used to calculate large, conformationally diverse pools of structures. Two pools were created from starting structure 1. One
(black) was not subjected to any constraints, while the second pool (red) was restricted to Rg values of <35 Å to limit the pool to structures that ﬁt
more closely with the experimentally determined Rg values. Starting structure 2 was not subjected to any additional constraints for the generation of
its corresponding single pool of structures (blue). Two separate structural pools were also generated from starting structure 3; one (pink) had no
additional constraints imposed, and the second (green) was limited to Rg values of <35 Å and also had constraints imposed to maintain the IDD
conformation wrapped around PAI-1. The pools of structures were compared with the SANS data from the 85% D2O condition using χ2 analyses.
As one can see from this plot, the two pools generated from starting structure 1 best ﬁt the 85% contrast data. (b) χ2 vs Rg plot for SANS data on
the PAI-1:SMB-IDD complex at all contrasts. The 1797 structures with the lowest χ2 values from starting structure 1 (red data points in panel a)
were compared with the SANS measurements at all contrasts for goodness of ﬁt and are depicted in a χ2 vs Rg plot. The red points are from the 85%
D2O data and are the same as the red points in panel a. The gray and purple points are from the 20% and 0% D2O data, respectively.

D2O, from which the scattering curves in Figure 9 were
calculated. This resulted in 30 structures that ﬁt the SANS data
with χ2 < 4 in 85% D2O, χ2 < 15 in 20% D2O, and χ2 < 20 in
0% D2O, as illustrated in Figure 10. Because all 30 of these
structures ﬁt the SANS data at all three contrasts, it follows
that linear combinations of these structures can be found that
also ﬁt the SANS data at all three contrasts. In addition, the
average scattering curve for all of the structures also will ﬁt the
SANS data at all three contrasts, meaning that all of the
structures in this ensemble could exist in the solution.
Furthermore, it is reasonable to assume that additional
structures can be found that would also be a good ﬁt to the
data at all three contrasts. Table S3 lists the Rg values of PAI-1
and SMB-IDD in the complex, along with the CM distance
between them, for the 30 best ﬁt structures at all contrasts
from Figure 10. Rg for PAI-1 is ﬁxed at 21.86 Å, but that for
SMB-IDD varies between 28 and 38 Å. CM distances range
from 20 to 33 Å. In addition, the CM distances and Rg of SMBIDD are coupled in the sense that those structures with larger
Rg values for SMB-IDD have smaller CM distances. The best
ﬁt structure (number 16) has an Rg of SMB-IDD (31.0 Å),
very close to that predicted from the Stuhrmann and parallel
axis theorem analyses (30.3 ± 0.3 Å). However, the CM
distance between PAI-1 and SMB-IDD (27.5 Å) is larger than
the predicted value (18 ± 1 Å).

space to which the IDD is localized under the two conditions.
It is noteworthy that starting structure 1, which has the least
conformational restraints of all three starting structures, was
used for this density plot, avoiding biasing of conformational
space to more compact structures. The agreement of this
modeling with the SANS data provides strong support for
adoption of a compact structure by the IDD upon interaction
with PAI-1. This observed adoption of structure appears not to
be simple steric restriction of the IDD region solely due to
binding of the SMB domain to PAI-1; comparison of data in
Figures 6 and 7 indicates that the SMB-IDD accesses the same
lower end of the conformational region (∼20−22 Å) under
experimental conditions with and without PAI-1 present.
The calculated SANS curves for the best ﬁt structure (χ2 =
1.29) for the 85% D2O data (from the ensemble colored red in
panels a and b of Figure 6) are shown along with the SANS
data in 0%, 20%, and 85% D2O in Figure 9. Given the
ﬂexibility of the IDD, it is unlikely that this single structure
exists in solution. Instead, multiple conformations of the IDD
likely are present and the average scattering from those
structures suggests that the IDD is compact. To explore
additional structures that may ﬁt the data as well as the best ﬁt
structure, the ensemble of structures represented by the χ2
versus Rg curves in Figure 6b was further mined to ﬁnd the
smallest set of structures that best ﬁt the SANS data at all
contrasts, while still containing the best ﬁt structure in 85%
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Figure 7. χ2 vs Rg plot for SANS on the unbound SMB-IDD. The free
SMB-IDD starting structure, shown in Figure 5, was used to generate
a large pool as described in Materials and Methods. As one can see in
the χ2 vs Rg plot, scaled only to show χ2 values of <20, the structural
pool generated from the SMB-IDD starting structure contains
calculated structures that ﬁt reasonably well to the SANS data for
free SMB-IDD in solution.

Figure 9. SANS data curves. Experimental SANS data are shown as
dots for the three contrast conditions used for the structure modeling.
The solid lines are the calculated SANS curves for the best ﬁt
structure to the 85% D2O data, with χ2 = 1.29, plotted for all three
contrasts. Error bars represent standard errors of the mean.

Figure 11. The best ﬁt structure (number 16) is located on the
bottom left. The 30 structures from the best ﬁt data set (Table
S3) share some common features. First, the region of the IDD
that is proximal in sequence to the SMB domain is more
restricted in conformational space compared to the more distal
regions of the IDD. The proximal IDD regions consistently
make a close approach to PAI-1, with a variety of
conformations represented in the examples shown in Figure
11. There appears to be much more conformational freedom
available to the distal IDD regions, which have variable to little
contact with PAI-1. Thus, the inherent ﬂexibility of the IDD is
apparent from the SANS analysis. However, with full-length
vitronectin, the IDD is anchored on the C-terminal end by the
central β-propeller domain and will have more limited
conformational freedom.

■

Figure 8. Density plots for unbound and bound SMB-IDD. (a)
Unbound SMB-IDD. The SMB region is colored cyan. The gray
cloud corresponds to unbound IDD structures with a χ2 value of <1.5.
(b) PAI-1:SMB-IDD complex. PAI-1 bound to the SMB domain is
shown at the center with PAI-1 colored green and the SMB domain
colored cyan. The amber-colored cloud displays the IDD region for
the 196 best ﬁt structures for the 85% D2O data, with a χ2 value of <4.
For comparison, the SMB region for the PAI-1:SMB-IDD complex is
superimposed on the SMB region for SBM-IDD alone in solution, and
the same conformational space for the unbound IDD is colored
lighter gray. The data demonstrate that, in the best ﬁt structures, the
IDD occupies a smaller range of three-dimensional space surrounding
PAI-1:SMB at the core of the PAI-1:SMB-IDD complex relative to the
space sampled by the structural ensemble for unbound SMB-IDD.

DISCUSSION
Vitronectin Contains an Intrinsically Disordered
Domain. We have a long-standing interest in understanding
the folding of vitronectin into individual domains and the
assignments of functions within domains. A domain organization for vitronectin was originally proposed solely on the
basis of sequence alignment24,101 and was supported by
computational queries using threading approaches, which
yielded a model with three domains in human vitronectin.1
Even in these early studies, the inability to provide a structural
model for the ∼80 amino acids that connected the N-terminal
and central domains prohibited the assembly of a full-length
model for vitronectin. Consequently, when intact vitronectin
was analyzed using small-angle X-ray scattering (SAXS) to
characterize the overall folding envelope, this ∼80-amino acid
linker sequence was reanalyzed using bioinformatics methods,
with the ultimate conclusion that the region was unstructured.
The unstructured character of this linker region agrees with a

Although individual structures are an imprecise method for
visualizing a complex with a large amount of ﬂexibility, they aid
in understanding complex formation. Therefore, we have
chosen to highlight several of the 30 best ﬁt structures at all
three contrasts as representative conformational states in
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Figure 10. Calculated SANS curves for the best ﬁt structures at all contrasts. Calculated SANS curves from the 30 structures that are in the best ﬁt
χ2 ensembles at all contrasts: (a) 85% D2O, best ﬁt ensemble deﬁned as χ2 < 4; (b) 20% D2O, best ﬁt ensemble deﬁned as χ2 < 15; and (c) 0%
D2O, best ﬁt ensemble deﬁned as χ2 < 20. Error bars represent standard errors of the mean.

Figure 11. Representative structures for the PAI-1:SMB-IDD complex from the best ﬁt ensemble at all contrasts. Six structures from the total 30
best ﬁt structures at all contracts are shown, corresponding to structure 7 (top left), structure 8 (top middle), structure 13 (top right), structure 16
(bottom left), structure 20 (bottom middle), and structure 26 (bottom right) from Table S3. The overall best ﬁt structure is structure 16, with a χ2
value of 1.29 (85% D2O). PAI-1 is colored green, the SMB cyan, and the IDD amber. The structures consistently show that the IDD region
proximal to the SMB makes close approaches to PAI-1, with the potential to form contacts with α-helices D and E in PAI-1. It is clear from these
representative structures that there is a large variation in the orientation of the distal end of the IDD.

variety of studies that have demonstrated its high susceptibility
to proteolysis.1 The SAXS experiments deﬁned a structural
envelope characterized by a bilobed structure with an average
Rg of 30.3 ± 0.6 Å and a maximum length of 110 Å.26
Interestingly, the narrowed region between the two lobes
appeared to be occupied by the linker sequence, which was
simply modeled as a cylinder that could be occupied by an
indeterminant, ﬂexible structure.
When the bilobed structure of vitronectin was described, we
noted the beneﬁt that a relatively disordered connecting region
could provide ﬂexibility between the two globular lobes. A
disorder-to-order transition in this linker region was postulated

to modulate speciﬁcity and/or aﬃnity in ligand binding. Over
the years, interest has developed in intrinsically disordered
proteins, which are prone to such disorder-to-order transitions,
typically in a coupled binding−folding event. Studies of
intrinsically disordered proteins are becoming more functionally relevant. We are now aware that intrinsically disordered
proteins display noteworthy functions in neural development,
synaptic transmission, and cell cycle regulation,102,103 and they
are embedded within many scaﬀolding proteins and also have
roles in signaling sequences.35,36,104−106 Intrinsic disorder is
emerging as a key feature in the versatility of living systems,
whereby simultaneous promiscuity and speciﬁcity in binding
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interactions are manifested.107 While novel functions can be
attributed to many IDD regions, the role of disordered regions
is not always apparent.
The linker region in vitronectin has hallmark features of
intrinsically disordered protein sequences. In particular, it
harbors a signiﬁcant number of acidic residues (Asp and Glu),
has a net negative charge, and exhibits charge repulsion
interactions.28 The hypotheses tested in this work are whether,
in fact, this region can be classiﬁed as an IDD region and
whether it undergoes a transition to adopt structure as we
originally predicted. To query the classiﬁcation of the
interdomain linker in VN as an IDD capable of adopting
structure, we used bioinformatic tools and experimental tests.
The use of multiple computational tools designed for
predicting the intrinsic disorder predisposition of a protein
on a per-residue basis revealed that IDD is expected to be
highly disordered. The inherent versatility of IDD regions is
attributed to their ability to adopt diverse structures when they
interact with diﬀerent binding partners. The disordered regions
that are prone to adopt such structures are denoted as
Molecular Recognition Features (MoRFs),12 and MoRF
prediction algorithms have pointed to segments of the VN
IDD that can potentially gain structure upon ligand binding.
Along with these predictions, we were able to demonstrate
experimentally that the linker region is disordered and
undergoes a disorder-to-order transition. Both CD and
SANS experiments conﬁrm that the IDD, being highly
disordered in aqueous solution, adopts structure and becomes
more compact when exposed to osmotic pressure. Therefore,
the computational modeling and experimental data support the
classiﬁcation of the linker region between the ﬁrst and third
domains of VN as an IDD region that gains structure under
given circumstances. Within the three-dimensional model for
VN generated by Lynn et al. from SAXS, NMR, and threading
predictions,26 the narrowest point in the bilobed model where
the IDD was mapped measures ∼35 Å. For comparison, the
SANS data indicate that the free SMB-IDD exhibits an average
Rg of ∼31 Å with a maximum linear dimension of ∼78 Å. This
classiﬁcation of the linker as an IDD provided a valuable
insight into this understudied domain of VN and prompted
further studies to test whether binding of the PAI-1 ligand
leads to a similar adoption of structure.
The Intrinsically Disordered Domain Houses a Site
for PAI-1 Binding. Localization and further characterization
of mutual interaction sites for PAI-1 and VN are important
features of this study. While the identity of PAI-1-binding sites
on vitronectin had been debated in early work, the primary
high-aﬃnity site for binding had been isolated within the SMB
domain of vitronectin and the identity of other “secondary”
sites for interaction remained uncertain but mostly ignored.
However, upon our identiﬁcation of additional vitronectinbinding sites on PAI-1, which were located outside of the
ﬂexible joint region,41 it became clear that a complementary
binding site outside of the well-characterized SMB domain of
vitronectin must be present. We judged the ﬂexible linker, now
known to be an IDD region, as a probable location for such a
binding site because of its complementary charge character and
inherent ﬂexibility. In a series of SANS experiments to test for
structural changes in the SMB-IDD, it was observed that PAI-1
binding led to structural reorganization of the IDD into a more
compact structure. This result localizes an additional binding
site for PAI-1 to the linker region in vitronectin.

Computational approaches with the PAI-1:SMB-IDD
complex were used to provide models that conform to the
SANS data measured with a series of solvents that diﬀered in
D2O levels in the contrast variation studies. The conformational space that is occupied in the density plots comparing
both the free and bound SMB-IDD (Figure 8) illustrates a
coupled folding−binding event with PAI-1 that leads to a more
compact IDD region. Among the ensemble of 30 best ﬁt
structures for the PAI-1:SMB-IDD complex (Figure 11), the
examples pictured illustrate close contacts that occur with PAI1 via the IDD region. In these representative structures from
the best ﬁt set (Table S3), a segment of the IDD sequence that
is proximal to the SMB domain adopts an orientation that
would allow contacts with helices D and E of PAI-1. This is
noteworthy because the basic residues that comprise the more
extensive binding site for vitronectin outside of the SMB
domain are located on these particular α-helices.41 While it
may be tempting to investigate these models to identify
potential binding residues, the resolution of SANS data does
not warrant this detailed query.
A Comprehensive Model of PAI-1:VN Binding.
Recognizing the noteworthy eﬀects that PAI-1 and vitronectin
confer on each other regarding function, assembly of
complexes, and tissue localization and speciﬁcity, we have
pursued a variety of approaches to deﬁne the binding interfaces
and to characterize conformational changes and association to
higher-order structures. For example, vitronectin localizes PAI1 to ﬁbrin clots,43 promotes accretion of PAI-1 in the ECM,108
and broadens the spectrum of PAI-1 inhibition to target other
serine proteases involved in coagulation.109,110 Also, PAI-1 and
vitronectin are localized together in the ECM in a variety of
pathologies, including inﬂammation, tumor development,
angiogenesis, and necrosis.111−113 Vitronectin found in the
ECM adopts an oligomeric form114 and can engage a variety of
cell surface receptors. Through analyses of the eﬀects of PAI-1
on vitronectin over a >24 h time course, we established that
PAI-1 promotes the assembly of higher-order oligomers that
exhibit enhanced interactions with integrins and ECM
components.115 We also used analytical ultracentrifugation to
demonstrate that PAI-1 and vitronectin interact in a 2:1
stoichiometry and assemble to higher-order multimers via a
discrete 4:2 complex.100
A model for association of these PAI-1:vitronectin
complexes suggested multiple binding sites and conformational
changes that promote higher-order assemblies.100 Stoppedﬂow kinetics established that full-length vitronectin and PAI-1
interact in two phases, whereas the SMB domain alone exhibits
only one phase in binding.37 Conformational changes were
detected in both proteins upon binding, and these structural
changes occurred on a slower time frame compared to the
initial binding phases.37 Such conformational changes are
proposed to be essential for association of the altered,
oligomeric form of vitronectin. Furthermore, the conformational change induced by the binding of full-length vitronectin
to PAI-1 diﬀered from that induced by the SMB domain alone.
Also, the rapid reaction kinetics for attack of target proteases
diﬀered comparing free PAI-1 with complexes containing
vitronectin or the SMB domain.37 These data were some of the
ﬁrst to demonstrate that a binding site for PAI-1 existed
outside of the SMB domain and oﬀered direct evidence of a
folding−binding event leading to an altered structure upon
binding of PAI-1 to vitronectin.
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scale that mirrors the rate of decay of PAI-1 from the active to
latent form. Evidence from our concurrent study demonstrates
that the PAI-1-binding site housed in the IDD contributes to
the initial biphasic binding.46 The structural changes in this
region are proposed to transduce structural changes throughout VN, leading to the altered multimeric structure that is most
eﬀective in binding to ECM components and cell surface
receptors. The characterization of an IDD in VN provides
insight into the adaptability that VN may exhibit in binding
ligands and in biological functions.

Compelling support for a second PAI-1-binding site on
vitronectin came from our studies of a form of vitronectin
(rΔsBVN) that had the somatomedin B domain deleted yet
retained PAI-1 binding.40 The rΔsBVN protein partially
inhibited binding of PAI-1 to full-length vitronectin and
exhibited a Kd of 30 nM (much weaker than binding of intact,
full-length vitronectin containing the somatomedin B domain,
which is ∼0.3 nM116−120). The rΔsBVN protein was used to
map the complementary site on PAI-1 to a region outside of
the somatomedin B binding area and localize it to the distal
ends of α-helices D and E.41 For the study presented here,
another form of vitronectin with a deleted sequence, which
contains the SMB domain and the ∼80-amino acid linker but
lacks the rest of the C-terminus, was studied. This linker region
is present in both the SMB-IDD and the rΔsBVN studied
previously. Thus, the SMB-IDD was generated to determine
whether the IDD accounts for the PAI-1-binding epitope in
rΔsBVN. The data from SANS are consistent with this idea,
with the best ﬁt structures for the SMB-IDD observed to be
more compact upon binding. Thus, the data suggest that the
SMB-IDD exhibits the expected coupled folding−binding
behavior.
The study with the rΔsBVN form of VN also demonstrated
a salt dependence in the assembly of the higher-order PAI1:vitronectin multimers, with higher salt concentrations
disfavoring assembly to the higher-order species.40 In contrast,
ionic strength does not strictly disrupt the binding of PAI-1 to
intact vitronectin,115 presumably because the contacts
identiﬁed between amino acids in the ﬂexible joint region
and residues in the SMB domain are not sensitive to salt
concentrations. The structural models for the PAI-1:SMB-IDD
complex generated from the SANS analysis demonstrate a
close approach of regions of the IDD with PAI-1 beyond the
SMB-binding region. As noted above, the more extensive
vitronectin-binding site recently identiﬁed outside the ﬂexible
joint region on PAI-1 contains several basic amino acids within
helices D and E,41 and the IDD hosts a number of
complementary acidic residues within regions that make a
close approach in the structural models from this SANS work
(Figure 11). The results from this SANS analysis have been
expanded with a complementary protein engineering and
kinetics approach to study PAI-1:vitronectin binding.46 This
parallel study utilized a vitronectin fragment containing a
truncated IDD to demonstrate a biphasic binding event with
the SMB-IDD, narrowing down the binding site within the
IDD to a 24-amino acid region and utilizing molecular
dynamics to identify four charge:charge interactions within the
binding site.46 Thus, the binding between charged residues in
the IDD and amino acids within the more extensive binding
epitope on PAI-141 should be disrupted by salt and prevent the
coupled folding−binding event observed in this work.
Over many years, we have worked to address the hypothesis
that stepwise binding of PAI-1, in a concentration-dependent
pathway, is required to form higher-order PAI-1:vitronectin
complexes. This SANS study contributes to a unifying model
that is consistent with the large body of cumulative work on
the binding of vitronectin to PAI-1 that has the following steps
in a time sequence: (1) rapid association of PAI-1 with
vitronectin in a concentration-dependent, biphasic fashion, (2)
conformational changes in both PAI-1 and vitronectin, (3)
assembly of higher-order complexes with multimers of
vitronectin that persist in an altered conformation, and (4)
dissociation of latent PAI-1 from the complexes on a slow time
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